Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seed Fonds III for the region of Aachen is a venture capital fund dedicated to supporting early-stage technology startups in the Aachen region of Germany. Managed by the S-UBG Group, the fund provides essential seed capital to innovative companies in the life sciences, biotechnology, and medical technology sectors. It acts as a crucial link between academic research, particularly from RWTH Aachen University, and commercial market entry. The fund is supported by a partnership of regional savings banks, NRW.BANK, and private investors. Beyond financial investment, the fund offers strategic guidance and access to an extensive network of industry experts and corporate partners. Its portfolio includes a diverse range of high-tech ventures focused on developing novel therapeutics, diagnostics, and digital health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seed Fonds III for the region of Aachen.